Edesa Biotech, Inc.
Key Metrics
Market Snapshot
About
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for inflammatory and immune-related diseases. The company's lead product candidate, EB05, is being investigated for acute respiratory distress syndrome and other conditions involving excessive inflammation. Edesa is also developing dermatology treatments and other antibody-based therapies targeting unmet medical needs. Headquartered in Ontario, Canada, the company focuses on repurposing and advancing novel applications of antibody platforms through clinical development.